
India to get first dengue vaccine in 2027 as Qdenga approved
The story in brief
India is set to receive its first dengue vaccine, Qdenga, in the first half of 2027, following its approval by the drug regulator in July. The vaccine, developed by Takeda, showed 90.4% efficacy against hospitalisations after 18 months and has a two-dose schedule. Over 24 million doses have been distributed globally, with favorable safety profiles reported.